Cargando…

OR26-01 A Novel Small Molecule Thyrotropin Receptor Antagonist

Disclosure: G.J. Kahaly: None. A. George: None. L. Steiner: None. T. Weirauch: None. J. Henseling: None. L. Frommer: None. J. Wolf: None. Background & aims: Treatment of both Graves’ hyperthyroidism (GH) and Graves’ orbitopathy (GO) is still far from adequate, hence new therapeutic modalities, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kahaly, George Jean, George, Augustine, Steiner, Lisa, Weirauch, Tobias, Henseling, Jil, Frommer, Lara, Wolf, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554978/ http://dx.doi.org/10.1210/jendso/bvad114.2050

Ejemplares similares

FRI537 Thyrotropin Receptor Blocking Antibodies - A Multicenter, 4-Assay Comparison
por: George, Augustine, et al.
Publicado: (2023)

FRI540 A Novel, Rapid, Sensitive Bioassay For Thyrotropin Receptor Stimulatory Antibodies Improves Diagnosis & Management Of Autoimmune Thyroid Disease
por: Jean Kahaly, George, et al.
Publicado: (2023)

MON-583 Functional Thyrotropin Receptor Antibodies in Pregnant Women with Thyroid Autoimmunity
por: Diana, Tanja, et al.
Publicado: (2019)

SAT-557 Functional Thyrotropin Receptor Antibodies Confirm a Novel Graves' Disease Animal Model
por: Diana, Tanja, et al.
Publicado: (2019)

SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy
por: Lee, Alan C H, et al.
Publicado: (2020)

OR18-01 Effect of Teprotumumab on Proptosis Reduction Across Various Demographic Sub-Groups
por: Kahaly, George J, et al.
Publicado: (2020)

Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
por: Kahaly, George J, et al.
Publicado: (2019)

Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline
por: Saand, Aisha R, et al.
Publicado: (2021)

Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy
por: George, Augustine, et al.
Publicado: (2021)

LBSAT244 Prospective, Blinded, Multicenter Head-to-head Clinical Comparison Of Two "TSI" Assays In Patients With Autoimmune Thyroid Disease
por: Lupo, Mark Armin, et al.
Publicado: (2022)

MON-593 Thyrotropin Receptor Stimulating Immunoglobulin: Clinical Utility in Graves' Disease Diagnosis
por: Marques, Bernardo, et al.
Publicado: (2019)

ODP509 Proof-of-concept, Multicenter, Open-Label Phase 2a Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease
por: Janes, Jonathan, et al.
Publicado: (2022)

SAT459 Teprotumumab Pooled Efficacy From The European Study Sites Participating In The Phase 2, OPTIC (Phase 3) And OPTIC-X Pivotal Trials
por: Kahaly, George J, et al.
Publicado: (2023)

FRI476 Asymptomatic Thyrotropin-secreting Pituitary Microadenoma With Biochemical Secondary Hyperthyroidism: A Diagnostic Conundrum
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)

OR18-03 Functional TSH Receptor Antibodies Are a Biomarker for Graves’ Disease - a Prospective Trial
por: Kahaly, George Jean, et al.
Publicado: (2020)

MON-LB100 Worse Clinical Characteristics and More Unsatisfactory Therapeutic Outcomes in Coexisting Thyrotropin Pituitary Adenomas
por: Han, Huiqiao, et al.
Publicado: (2019)

SAT-443 Impact of Fasting on Plasma Thyrotropin in Hypothyroid Patients Taking Levothyroxine During Ramadan (IFT-R Study)
por: El-Kaissi, Samer, et al.
Publicado: (2020)

FRI474 Panhypopituitarism And Central Hypothyroidism Presenting As Myoclonus And Hyperreflexia, An Unusual Presentation Likely Related To Thyrotropin-releasing Hormone
por: Nadeem, Ifrah, et al.
Publicado: (2023)

Thyrotropin Receptor Blocking Antibodies
por: Diana, Tanja, et al.
Publicado: (2018)

RF35 | PSAT269 Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase 2b Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease
por: Kahaly, George, et al.
Publicado: (2022)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

SAT-450 Essential Role of GATA2 in the Negative Regulation of the Prepro-Thyrotropin-Releasing Hormone Gene by Liganded T3 in the Rat Paraventricular Nucleus
por: Kuroda, Go, et al.
Publicado: (2020)

OR11-4 Teprotumumab Markedly Improves Disease-related Quality of Life: Lessons From Two Randomized, Placebo-controlled Trials
por: Douglas, Raymond S, et al.
Publicado: (2022)

SAT-LB80 Elevated Pre-Op Thyrotropin Levels Are Associated With Increased 30-Day Mortality in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
por: Masoodi, Shariq Rashid, et al.
Publicado: (2020)

ODP460 Age- and sex- specific reference ranges for serum thyrotropin (TSH), free T4 and free T3 levels: Significant effects on the definition of subclinical dysfunction
por: Yamada, Sayaka, et al.
Publicado: (2022)

OR01-01 Human Type 1 Iodothyronine Deiodinase (DIO1) Mutations Cause Abnormal Thyroid Hormone Metabolism
por: França, Monica Malheiros, et al.
Publicado: (2020)

SAT-565 The Surface Of Liganded T3 Receptor β2 For Steroid Receptor Coactivator 1 And 2 Mediates The Negative Regulation Of The Prepro-thyrotropin-releasing Hormone Gene By T3
por: Sakai, Yuki, et al.
Publicado: (2019)

OR19-6 A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, Successfully Treats Graves’ Hyperthyroidism
por: Kahaly, George, et al.
Publicado: (2019)

OR26-02 VRDN-001, A Full Antagonist Antibody To IGF-1 Receptor In Development For Thyroid Eye Disease (TED), Binds To A Distinct Epitope From Teprotumumab
por: Bedian, Vahe, et al.
Publicado: (2023)

OR01-05 Long-Term Efficacy of T3 Analogue Triac in MCT8 Deficiency
por: van Geest, Ferdy S, et al.
Publicado: (2020)

OR01-04 Kruppel-Like Factors 9 and 13 Cooperate to Maintain Mammalian Neuronal Differentiation
por: Avila-Mendoza, Jose, et al.
Publicado: (2020)

OR01-03 Thyroid Receptor Alpha Interacts with COUP-TFII in the Regulation of Postnatal Skeletal Muscle Regeneration
por: Aguiari, Paola, et al.
Publicado: (2020)

High Thyrotropin Is Critical for Cardiac Electrical Remodeling and Arrhythmia Vulnerability in Hypothyroidism
por: Fernandez-Ruocco, Julieta, et al.
Publicado: (2019)

Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020)

OR14-01 Contact Between Thyroglobulin Opposite Domains Assists Its Upstream Regions In Intracellular Trafficking For Thyroid Hormonogenesis
por: Citterio, Cintia E, et al.
Publicado: (2023)

OR28-01 Constitutive Activation of NRF2 Antioxidant Response Leads to Age-Dependent Goiter and Compensated Hypothyroidism in Male Mice
por: Chartoumpekis, Dionysios, et al.
Publicado: (2020)

OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

Type 1 diabetes and associated autoimmune diseases
por: Frommer, Lara, et al.
Publicado: (2020)

Type 1 Diabetes and Autoimmune Thyroid Disease—The Genetic Link
por: Frommer, Lara, et al.
Publicado: (2021)

Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tl3sqof5fhdnp62o9n6h8fbq0